Editorial
Editor-in-Chief eMediNexus – Dr KK Aggarwal
 
1st March 2019

Can you be punished for something, which is not a part of the charge sheet?

Dr KK Aggarwal, Recipient of Padma Shri

The judgement of the Calcutta High Court in the matter of Snigdhendu Ghosh vs State of West Bengal & Ors on 19 July, 2018 has answered many questions that arise when a medical negligence case is filed against a doctor, as follows:

  • Limitation period in filing a complaint
  • Can you be punished for something which is not a part of the charge sheet?
  • When can you appeal to GOI as a remedy?
  • Can the high courts interfere before all the remedies are exhausted?
  • Can a council go to the Supreme Court?...read more

Do you reuse your cooking oil?
FSSAI directs food business operators not to re-use cooking oil directly in food preparation nor re-enter food chain

Dr KK Aggarwal & Advocate Ira Gupta

FSSAI has issued directions under Section 16(5) of Food Safety and Standards Act, 2006 vide circular bearing F.No. 1-2/Stds/O&F/Notification n(II)/FSSAI-2018 dated 30.01.2019 regarding disposal and collection of used cooking oil (UCO).

Repeated use of oil leads to changes in physiochemical, nutritional and sensory properties of edible oil. During frying Total Polar Compounds are formed in the oil which has adverse effects on health.....read more

Practice Updates

Heat Wave 2019: Workshop on Preparedness begins in Nagpur

National Disaster Management Authority (NDMA) in collaboration with the Government of Maharashtra is conducting a two-day national workshop on Preparedness, Mitigation and Management of Heat Wave in Nagpur began yesterday.... read more


'2nd Edition of ISL Dictionary' for hearing impaired persons launched

The Union Minister for Social Justice and Empowerment, Shri Thaawarchand Gehlot, launched the "2nd Edition of Indian Sign Language (ISL) Dictionary" brought out by ‘Indian Sign Language Research and Training Centre (ISLRTC)' under Department of Empowerment of Persons with Disabilities.... read more


Lotemax SM approved for ocular surgery pain and inflammation

The US Food and Drug Administration (FDA) has approved a new formulation of loteprednol etabonate ophthalmic gel (Lotemax SM, Bausch + Lomb) 0.38% for postoperative inflammation... read more


Generic drugs may be color coded for easy identification

After making separate shelves for displaying generic drugs mandatory at pharmacies, the Central government is planning to introduce color-coding and symbols to identify generic medicines and promote their consumption. The identification mechanism, similar to the one used to differentiate food products of vegetarian and non-vegetarian origin, is weighed by the Drug.... read more


Resistance training even as little as once per week benefits older individuals

According to a recent research published in Experimental Gerontology, resistance training improves the health of over 65-year-olds, and the benefits occur even when some people train as little as once per week..... read more


FDA cautions about using thermography as a tool for breast cancer screening

In a safety communication issued Feb. 25, 2019, the FDA is alerting women, health care providers, and people getting breast cancer screening, that thermography is not an effective alternative to mammography and should not be used in place of mammography for breast cancer screening or diagnosis.... read more

Medical Voice

Overlapping Surgery Largely Safe but surgeons should not take simultaneous high risk or bypass surgery cases

Overlapping surgery means when the primary surgeon is involved in more than one case simultaneously. In a JAMA study across seven common surgeries: total knee or hip arthroplasty; lumbar, thoracic, or cervical spine surgery; coronary artery bypass graft (CABG) surgery; and craniotomy;.... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Insulin.
2. Corticosteroid.
3. Epinephrine.
4. Glucagon.
Lifestyle Updates
 
Inspirational Story 1: Family
Inspirational Story 2: The Comfort Zone
Capping the price of anti-cancer drugs is a welcome move
There is also a need to bring about initiatives that can help in the early diagnosis of cancer
 
New Delhi, 28th: The government has brought 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30%. This would reduce their retail prices by up to 85%. The National Pharmaceutical Pricing Authority (NPPA) has invoked extraordinary powers in public interest, under Para 19 of the Drugs (Prices Control) Order, 2013 to bring 42 non-scheduled anti-cancer drugs under price control through trade margin rationalization.

As per data available with NPPA, the MRP for 105 brands will be reduced up to 85% entailing minimum saving of 105 crore to consumers. Currently, 57 anti-cancer drugs are under price control as scheduled formulations.

To Read More or Comment, Click Here